Aarti Drugs, a small-cap player in the Pharmaceuticals & Biotechnology sector, has shown impressive performance today, gaining 7.04% on July 15, 2025. This surge has allowed the stock to outperform its sector by 6.78%, reflecting a strong upward trend. Over the past two days, Aarti Drugs has recorded a cumulative return of 8.69%, indicating a consistent positive momentum.
The stock reached an intraday high of Rs 514.8, marking a 7.13% increase during the trading session. Notably, Aarti Drugs is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a robust market position.

In the broader market context, the Sensex has also experienced a positive shift, climbing 428.23 points to reach 82,661.39, after a flat opening. The small-cap segment is leading the market, with the BSE Small Cap index gaining 0.94%. Aarti Drugs' performance over various time frames further highlights its resilience, with a 44.18% increase over the past three months, compared to the Sensex's 7.71% rise.